Apharmas Announces Launch of Cellipon293™, a Novel Transfection Reagent

Cellipon293™, a novel in vitro cationic lipid transfection reagent, is specifically developed for the delivery of DNA/RNA into HEK-293 cells as well as broad mammalian cells.

With high transfection efficiency, low cytotoxicity, and simple protocol, Cellipon293™ enables researchers to get satisfactory results easy and fast. It is also very cost-effective ($98.40 /ml), only about 30% comparing to major brand products’ price, which provides a good option to low-budget laboratories and high volume users.